![]() |
|
|
Vol. 282, Issue 2, 657-662, 1997
-Tocopherol Metabolite LLU-
1
Laboratory of Chemical Endocrinology, Loma Linda University School
of Medicine, Loma Linda, California (E.D.M. Jr., W.J.W., D.K., T.P.,
D.D.Q., K.M.G., D.L.),
Department of Pharmacology, New York Medical
College, Valhalla, New York (W.-H.W.) and
Department of Pharmacology,
Geneva University School of Medicine, Geneva, Switzerland (B.M.A.)
The structural elucidation and mechanism of action of a potential
component, LLU-
, of what is possibly a multifactorial complex known
as "natriuretic hormone" was recently reported [Wechter, W.J.
et al. (1996a) Proc. Natl. Acad. Sci. U.S.A. 93:
6002-6007]. "Natriuretic hormone," a long-sought factor, is
believed to regulate extracellular fluid volume and consequently be
pathomimetic for hypertension, cirrhosis, congestive heart failure and
other volume expanded states. The studies reported herein further
characterize LLU-
. The precursor of the endogenous LLU-
was demonstrated to be
-tocopherol by radiolabeling studies. The
pharmacokinetics of infused rac-LLU-
proved to
be biphasic (half-lives: 12 min and 6 h). Specificity of the
inhibition of the 70 pS potassium channel of the thick ascending limb
of the loop of Henle was examined with the natural
S-enantiomer being the most potent known inhibitor whereas
the analogous
-tocopherol metabolite,
rac-5-Me-LLU-
, showed no inhibition.
Rac-LLU-
does not inhibit two isozymes of the
Na+/K+-ATPase.
LLU-
is natriuretic acting via inhibition of
the 70 pS potassium channel and not
Na+/K+-ATPase, the
assumed mechanism of action of the "natriuretic hormone." LLU-
, a metabolite of a vitamin, if it were found to play
a role in the regulation of extracellular fluid volume, would be the second example of a vitamin acting as a precursor for a hormone. Of
considerable interest is the fact that this manuscript reports the
first biological activity of
-tocopherol, a member of the vitamin E
complex.
This article has been cited by other articles:
![]() |
S.-K. Park, G. P. Page, K. Kim, D. B. Allison, M. Meydani, R. Weindruch, and T. A. Prolla {alpha}- and {gamma}-Tocopherol Prevent Age-Related Transcriptional Alterations in the Heart and Brain of Mice J. Nutr., June 1, 2008; 138(6): 1010 - 1018. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Akaho, J. Takata, T. Fukushima, K. Matsunaga, A. Hattori, R. Hidaka, K. Fukui, M. Yoshida, T. Fujioka, Y. Karube, et al. Preparation and In Vivo Evaluation of a Water-Soluble Prodrug for 2R-{gamma}-Tocotrienol and as a Two-Step Prodrug for 2,7,8-Trimethyl-2S-({beta}-carboxyethyl)-6-hydroxychroman (S-{gamma}-CEHC) in Rat Drug Metab. Dispos., September 1, 2007; 35(9): 1502 - 1510. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Gaby Vitamin E Supplementation, Cardiovascular Events, and Cancer JAMA, July 27, 2005; 294(4): 425 - 425. [Full Text] [PDF] |
||||
![]() |
H. Saito, C. Kiyose, H. Yoshimura, T. Ueda, K. Kondo, and O. Igarashi {gamma}-Tocotrienol, a vitamin E homolog, is a natriuretic hormone precursor J. Lipid Res., August 1, 2003; 44(8): 1530 - 1535. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. JIANG and B. N. AMES {gamma}-Tocopherol, but not {alpha}-tocopherol, decreases proinflammatory eicosanoids and inflammation damage in rats FASEB J, May 1, 2003; 17(8): 816 - 822. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Takata, R. Hidaka, A. Yamasaki, A. Hattori, T. Fukushima, M. Tanabe, K. Matsunaga, Y. Karube, and K. Imai Novel d-{gamma}-tocopherol derivative as a prodrug for d-{gamma}-tocopherol and a two-step prodrug for S-{gamma}-CEHC J. Lipid Res., December 1, 2002; 43(12): 2196 - 2204. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Jiang, S. Christen, M. K Shigenaga, and B. N Ames {gamma}-Tocopherol, the major form of vitamin E in the US diet, deserves more attention Am. J. Clinical Nutrition, December 1, 2001; 74(6): 714 - 722. [Abstract] [Full Text] |
||||
![]() |
Q. Jiang, I. Elson-Schwab, C. Courtemanche, and B. N. Ames gamma -Tocopherol and its major metabolite, in contrast to alpha -tocopherol, inhibit cyclooxygenase activity in macrophages and epithelial cells PNAS, September 22, 2000; (2000) 200357097. [Abstract] [Full Text] |
||||
![]() |
Q. Jiang, I. Elson-Schwab, C. Courtemanche, and B. N. Ames gamma -Tocopherol and its major metabolite, in contrast to alpha -tocopherol, inhibit cyclooxygenase activity in macrophages and epithelial cells PNAS, October 10, 2000; 97(21): 11494 - 11499. [Abstract] [Full Text] [PDF] |
||||